what is bpc-157 used for BPC-157: Miracle Healing Peptide or Hidden Danger? Lot #:Lot #: N9BPC15710/0328 MIC B12 cell signaling research

what is bpc-157 used for BPC-157: Miracle Healing Peptide or Hidden Danger? Lot #:Lot #: N9BPC15710/0328 MIC B12 cell signaling research

MIC B12

MG TABLET MUPATIN 200 SR TABLET - ACEBROPHYLLINE(200MG) SUSTAINED RELEASE TABLET MUPATIN 600 TABLET - ACETYLCYSTEINE B.P 600MG EFFERVESCENT TABLET NEFROBEST TABLET NEBILOCK S TABLET - Nebivolol (5mg) + S-Amlodipine (2.5mg) NEBILOCK 5 TABLET - Nebivolol 5 mg NEBILOCK 2.5 TABLET - Nebivolol 2.5 mg MUPATIN AB TABLET - ACEBROPHYLLINE(100MG) + ACETYLCYSTEINE(600MG) NAPRODIN 250 TABLET - NAPROXEN(250MG) & DOMPERIDONE(10MG) TABLET NAPRODIN- 500 TABLET - NAPROXEN(500MG) TABLET NAPRODIN D 250TABLET - NAPROXEN(250MG) & DOMPERIDONE(10MG) TABLET NAPRODIN-D 500TABLET - NAPROXEN(500MG) & DOMPERIDONE(10MG) TABLET NAPROSAFE GOLD CAPSULE NAPROVIT 'H' WOMEN TABLET NAROSIP TZ TABLET - Norfloxacin (400mg) + Tinidazole (600mg) + Excipients Q.s

cell signaling research

Lot #:Lot #: N9BPC15710/0328

The open questions FDA raised cover the product as much as the molecule: Peptide identity: FDA found KPV “not well-characterized,” partly due to naming that skips INN, IUPAC, and USAN standards Purity and impurities: no information on the nature of individual impurities Sterility and microbial quality: no testing data for topical formulations Immune reactions and aggregation: “insufficient data to conclude that KPV (free base) or KPV acetate do not present these risks” Long-term exposure: no human data of any duration Topical, injectable, and oral forms each carry their own risk profile